Two monovalent vaccines that protect against serogroup B (MenB-4C and MenB-FHbp) are available. All children should receive a quadrivalent conjugate vaccine at age 11 or 12 years, with a booster dose at age 16 years (see also the routine childhood vaccination schedule).